ORK:EURONEXT OSLOOrkla ASA Analysis

Orkla trades at NOK 106, comfortably above its 20‑day (≈103.15) and 50‑day (≈105.38) SMAs but still below the 200‑day SMA (≈111.02), indicating short‑term strength within a longer‑term downtrend. The RSI sits at 64.3, below overbought levels, while the MACD histogram is positive and the signal line is bullish, suggesting momentum may be turning higher. Volume has been decreasing and the 30‑day volatility is elevated at 23.2%, yet beta is near zero (‑0.01), so price swings appear largely isolated from broader market moves. Recent earnings news cites robust organic growth and earnings expansion despite cost pressures, underscoring resilient operating performance.
Fundamentally, the company delivers a 3.68% dividend yield with a 62% payout ratio, supported by NOK 6.87 bn of free cash flow, and a solid ROE of 13.6%. Valuation metrics are mixed: a forward PE of 15.4 and a P/B of 2.19 appear reasonable, but the DCF‑derived fair value of NOK 83.4 is well below the current price, implying the stock is modestly overvalued. Analysts rate the stock as a “hold” with a median target of NOK 113, reflecting roughly 8% upside potential while acknowledging the modest 1.3% revenue growth and a debt‑to‑equity of 37%.